| 货号 | 10956-500mg |
| 描述 | Peroxisome proliferator-activated receptor α (PPARα) is a ligand-activated transcription factor involved in the regulation of lipid homeostasis.1,2 Activation of PPARα results in expression of a variety of genes, particularly those involved in fatty acid β-oxidation, binding, and transport.3 Clofibrate is a PPARα agonist and a member of a class of hypolipidemic drugs that includes fenofibrate and benzafibrate, which have been used clinically to treat dyslipidemia and cardiovascular disease. In a transactivation assay, clofibrate exhibits EC50 values of 50 and 55 µM for mouse and human PPARα, respectively.4 It also binds to PPARγ, but with 10-fold less affinity and is inactive at PPARδ at concentrations up to 100 µM.4 |
| 供应商 | Cayman |
| 应用文献 | |
| 1.Latruffe, N. and Vamecq, J. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Biochimie 79, 81-94 (1997). 2.Lemberger, T.,Desvergne, B. and Wahli, W. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology. Annual Reviews of Cell Development and Biology 12, 335-363 (1996). 3.Mandard, S.,Müller, M. and Kersten, S. Peroxisome proliferator-activated receptor α target genes. Cellular and Molecular Life Sciences 61, 393-416 (2004). 4.Willson, T.M.,Brown, P.J.,Sternbach, D.D., et al. The PPARs: From orphan receptors to drug discovery. Journal of Medicinal Chemistry 43(4), 528-550 (2000). | |
| 运输条件 | Room temperature in continental US; may vary elsewhere |
| 存放说明 | -20 |
| 纯度 | ≥98% |
| 计算分子量 | 242.7 |
| 分子式 | C12H15ClO3 |
| CAS号 | 637-07-0 |
| 稳定性 | ≥ 1 year |
| 本官网所有报价均为常温或者蓝冰运输价格，如有产品需要干冰运输，需另外加收干冰运输费。 |